Mar 31, 2026 06:19AM
Oct 1, 2024 06:00AM
Nov 4, 2022 04:03PM
Nov 4, 2022 04:01PM
Aug 31, 2021 09:19AM
Mar 16, 2021 01:30PM
Feb 18, 2021 04:01PM Pipeline and capital for growth
Dec 15, 2020 04:16PM
Dec 15, 2020 04:15PM
Nov 5, 2020 04:01PM
Sep 15, 2020 01:01PM
Aug 25, 2020 04:57AM
Aug 19, 2020 09:42AM
Aug 19, 2020 09:26AM Pre-Open Stock Movers 08/19: (MNTA) (HUD) (IMVT) Higher; (BMRN) (GLPG) (VIPS) Lower (more...)
Aug 19, 2020 06:11AM
Aug 19, 2020 06:10AM
Aug 18, 2020 07:25PM
Jun 10, 2020 12:58PM
Jun 5, 2020 04:02PM
Jun 5, 2020 04:01PM
Jun 5, 2020 04:01PM NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS
May 20, 2020 04:03PM
May 20, 2020 04:03PM
May 20, 2020 04:01PM
Jan 29, 2020 02:00AM
Dec 19, 2019 04:30PM
Nov 9, 2019 04:30PM
Nov 9, 2019 04:30PM NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILE
Oct 31, 2019 04:46PM
Oct 31, 2019 04:01PM
Oct 31, 2019 04:01PM
Oct 28, 2019 04:45PM
Oct 11, 2019 06:04AM
Oct 10, 2019 06:00PM
Oct 10, 2019 06:00PM GILEAD AND GALAPAGOS ANNOUNCE EFFICACY AND SAFETY RESULTS OF FILGOTINIB THROUGH 52 WEEKS IN FINCH 1 AND FINCH 3 STUDIES IN RHEUMATOID ARTHRITIS
Aug 7, 2019 04:05PM
Jul 25, 2019 04:02PM
Jul 23, 2019 07:00AM
Jul 14, 2019 02:53PM
Jul 2, 2019 01:01AM
Jun 11, 2019 06:10AM
Jun 11, 2019 01:01AM Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
May 29, 2019 04:31PM
Apr 23, 2019 04:15PM
Apr 23, 2019 04:02PM
Jan 29, 2019 06:22AM
Dec 17, 2018 04:24PM
Dec 17, 2018 04:20PM
Nov 27, 2018 04:23PM Galapagos NV (GLPG) Announces Fast Track Designation from FDA for GLPG1972/S201086 in Osteoarthritis
Nov 27, 2018 04:23PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All